Suppr超能文献

国立神经病学与中风研究院/进行性核上性麻痹协会和神经保护及帕金森叠加综合征自然病史研究协作组对于进行性核上性麻痹诊断的标准的准确性。

Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy.

机构信息

Department of Neurology, Philipps Universität, Marburg, Germany.

出版信息

Mov Disord. 2013 Apr;28(4):504-9. doi: 10.1002/mds.25327. Epub 2013 Feb 21.

Abstract

Autopsy is the diagnostic gold standard for progressive supranuclear palsy (PSP). The National Institute of Neurological Disorders and Stroke and Society for Progressive Supranuclear Palsy (NINDS-SPSP) criteria for the clinical diagnosis of "probable" PSP are thought to possess high specificity and low sensitivity. The NINDS-SPSP criteria for "possible" PSP are considered to increase sensitivity at the expense of specificity. The Neuroprotection and Natural History in Parkinson Plus Syndromes (NNIPPS) criteria are intended to improve sensitivity while maintaining high specificity. The aim of this study was to conduct a clinicopathological evaluation of the NINDS-SPSP and NNIPPS criteria in tertiary neurological centers. Defined clinical features and their year of onset were recorded by chart review in neuropathologically diagnosed patients with PSP, Parkinsons's disease (PD), MSA parkinsonism and corticobasal degeneration from four European brain banks. Fulfillment of the clinical diagnostic criteria was verified for each year after disease onset and for the final antemortem record. We analyzed 98 PSP patients and 46 disease controls. The NINDS-SPSP "probable" criteria yielded shorter time to diagnosis, slightly higher specificity and positive predictive value (PPV), and similar sensitivity, compared with the NNIPPS criteria. Unexpectedly, the NINDS-SPSP "possible" criteria yielded the lowest sensitivity, specificity, and PPV. A combination of NINDS-SPSP possible and probable criteria yielded the highest sensitivity. We suggest that the NINDS-SPSP probable criteria might be preferred for recruitment of patients for clinical trials, where an early and specific diagnosis is important. For routine clinical care, where high sensitivity is crucial, a combination of NINDS possible and probable criteria might be preferred.

摘要

尸检是进行进行性核上性麻痹(PSP)诊断的金标准。国家神经疾病和中风研究所和进行性核上性麻痹协会(NINDS-SPSP)制定的“可能” PSP 的临床诊断标准被认为具有高特异性和低敏感性。NINDS-SPSP 的“可能” PSP 标准被认为是以特异性为代价提高了敏感性。神经保护和帕金森加综合征自然史(NNIPPS)标准旨在提高敏感性的同时保持高特异性。本研究的目的是在三级神经中心对 NINDS-SPSP 和 NNIPPS 标准进行临床病理评估。通过对来自四个欧洲脑库的 PSP、帕金森病(PD)、MSA 帕金森病和皮质基底变性的神经病理学诊断患者的图表审查,记录了明确的临床特征及其发病年份。在发病后每年和最终发病前记录中,验证了临床诊断标准的满足情况。我们分析了 98 例 PSP 患者和 46 例疾病对照者。与 NNIPPS 标准相比,NINDS-SPSP“可能”标准可更早诊断,特异性和阳性预测值(PPV)略高,敏感性相似。出乎意料的是,NINDS-SPSP“可能”标准的敏感性、特异性和 PPV 最低。NINDS-SPSP“可能”和“可能”标准的组合可获得最高的敏感性。我们建议,对于临床试验中的患者招募,可能需要使用 NINDS-SPSP 可能标准,因为早期和特异性诊断很重要。对于常规临床护理,其中高敏感性至关重要,可能需要使用 NINDS 可能和可能标准的组合。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验